期刊文献+

金属型β-内酰胺酶及其抑制剂的研究概述 被引量:2

下载PDF
导出
摘要 金属型 β -内酰胺酶作为细菌产生 β -内酰胺类抗生素耐药的一种重要酶类 ,随 β -内酰胺类抗生素的广泛使用 ,耐药菌蔓延迅速 ,且无有效的抑制剂上市 ,因而受到国内外学者广泛关注。本文就金属 β -内酰胺酶种类、特性、作用机制和抑制剂等方面研究作一简要概述。
机构地区 中国药科大学
出处 《国外医药(抗生素分册)》 CAS 2004年第2期71-75,共5页 World Notes on Antibiotics
  • 相关文献

参考文献18

  • 1孙长贵,陈汉美.超广谱β-内酰胺酶研究进展[J].国外医药(抗生素分册),2000,21(3):111-115. 被引量:52
  • 2顾觉奋.药学进展专论[M].南京:南京大学出版社,1991..
  • 3Wang Z, Fast W, Benkovic SJ ,On the mechanism of the meetallo-beta-lactam&se from Bacte*wides fragilis [J]. Biochemistry, 1999,38(31): 10013.
  • 4Ambler RP.The structure of beta-lactamases [J] . Philos Trans R Soc London B Biol Sci , 1980,289(1036) : 321.
  • 5Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta lactamases and its correlation with molecular structure [J] . Antimicrob Agents Chemother, 1995, 39 ( 6 ) : 1211.
  • 6Philippon A, Dusart J, Joris B, et al. The diversity structure and regulation of beta-lactarnases [J] . Cell Mol Life Sci, 1998,54(6) :341.
  • 7Rasmussen BA, Bush K. Carbapenem-hydrolyzing beta-lacmmase[J]. Antimicrob Agents Chemother , 1997,41 (2):223.
  • 8Rossolini GM, Franceschini N, Riccio ML, et al. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B betalactamase showing a broad substrate profile [J]. Biochem J, 1998,332( Pt 1) : 145.
  • 9Ito H, Arakawa Y, Ohsuka S, et al. Plasmid- mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isoated strains of Serratia marcescens [J]. Antimicrob Agents Chemother, 1995,39 (4) : 824.
  • 10Osano E, Arakawa Y, Wacharotayankun R, et al. Molecular characterization of an enterobacterial metallo - beta- lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance [J]. Antimicrob Agents Chemother, 1994,38(1):71.

二级参考文献2

共引文献51

同被引文献10

  • 1Carine B.Metallo-β-lactamases(classification,activity,genetic,organization,structure,zinc coordination) and their superfamily[J].Biochem Pharm,2007,74:1686 -1701.
  • 2Toney JH,Moloughney JG.Metallo-beta-lactamase inhibitors:promise for the future?[J].Curr Opin investing Drugs,2004,5(8):823-826.
  • 3Walsh TR.Clinically significant carbapenemases:an update[J].Curr Opin Infect Dis,2008,21(4):367-371.
  • 4Wing YT,Anupma D,Christopher JS,et al.The inhibition of metallo β-lactamase by thioxo-cephalosporin derivatives[J].Bioorg & Med Chem,2004,14:1737-1739.
  • 5John DB,Hansong C,Lakshminaryana V,et al.Penicillin-derived inhibitors that simultaneously target both metallo and serine-β-lactamases[J].Bioorg &Med Chem,2004,14:1299-1304.
  • 6Sun Q,Andy L,Michael WC,et al.Homo-cysteinyl peptide inhibitors of the L1 metallo-β-1actamase and SAR as determined by combinatorial library synthesis[J].Bioorg & Med Chem,2006,16:5169-5175.
  • 7Mugesh ATG.Zinc and antibiotic resistance:metallo-β-lactamases and their synthetic analogues[J].Biol Inorg Chem,2008,13:1039-1053.
  • 8Benoit MR,Louise EH,Moreno G,et al.Inhibitors of the FEZ-1 metallo-βlactamase[J].Bioorg & Med Chem,2007,17:964-968.
  • 9Nauton L,Kahn R,Garau G,et al.Structural Insights into the Design of Inhibitors for the LI Metallo-β-Iactamase from Stenotrophomonas maltophilia[J].Mol.Biol,2008,375:257-269.
  • 10胡元生,温和.金属β-内酰胺酶研究进展[J].安徽医药,2007,11(12):1062-1064. 被引量:3

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部